VERA - Vera Therapeutics, Inc.

QQQ $ 472.49 $ -2.05 (-0.43 %)

DIA $ 416.26 $ -1.07 (-0.26 %)

SPY $ 562.20 $ -1.67 (-0.3 %)

TLT $ 99.62 $ -1.25 (-1.24 %)

GLD $ 235.53 $ -1.83 (-0.77 %)

Previous Close

$ 40.33

Open

$ 40.11

Bid

$ 40.32 x 100

Ask

-- x --

Day's Range

$ 39.34 - $ 42.13

52 Week Range

$ 9.24 - $ 50.78

Volume

562,123

Average Volume

Market Cap

2.21B

Beta (5Y Monthly)

$ 0.57

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-27-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-28-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-10-2022	06-30-2022	10-Q
10	05-16-2022	03-31-2022	10-Q
11	03-25-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-16-2021	06-30-2021	10-Q
14	06-24-2021	03-31-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cantor Fitzgerald Reiterates Overweight on...
09/16/2024 17:05:58

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Vera Therapeutics (NASDAQ:VERA) with a Overweight and maintains $107 ...

Vera Therapeutics To Host In-Person R&D Da...
09/16/2024 12:06:17

Vera Therapeutics, Inc. (NASDAQ:VERA), a late clinical-stage biotechnology company focused on developing and commercializing tr...

Vera Therapeutics Completes Enrollment For...
09/12/2024 12:01:29

On track to announce topline results from ORIGIN 3 trial in Q2 2025 Expect to present 96-week data from ORIGIN Phase 2b clinica...

Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 16:17:38

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Vera Therapeutics (NASDAQ:VERA) with a Overweight and maintains $107 ...

Cantor Fitzgerald Reiterates Overweight on...
09/06/2024 13:52:55

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Vera Therapeutics (NASDAQ:VERA) with a Overweight and maintains $107 ...

vaxcyte-shoals-technologies-polestar-automotive-applied-optoelectronics-and-other-big-stocks-moving-higher-on-tuesday

Vaxcyte, Shoals Technologies, Polestar Aut...
09/03/2024 14:47:56

JP Morgan Maintains Overweight on Vera The...
09/03/2024 13:54:40

JP Morgan analyst Anupam Rama maintains Vera Therapeutics (NASDAQ:VERA) with a Overweight and raises the price target from $...

JP Morgan Maintains Overweight on Vera The...
08/13/2024 12:39:25

JP Morgan analyst Anupam Rama maintains Vera Therapeutics (NASDAQ:VERA) with a Overweight and lowers the price target from $...

Vera Therapeutics Q2 EPS $(0.62) Misses $(...
08/08/2024 12:46:02

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $...

Vera Therapeutics Appoints David Johnson A...
07/01/2024 12:09:01

stericycle-marinemax-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-monday

Stericycle, MarineMax, Agios Pharmaceutica...
06/03/2024 14:39:44

wall-street-snaps-five-week-winning-streak-economic-growth-slows-inflation-holds-steady-in-april-this-week-in-the-market

Wall Street Snaps Five-Week Winning Streak...
05/31/2024 20:15:22

U.S. stock market ends 5-week positive streak due to slowing economic momentum, while Nvidia's valuation soars and home pri...

JP Morgan Maintains Overweight on Vera The...
05/31/2024 17:20:26

JP Morgan analyst Anupam Rama maintains Vera Therapeutics (NASDAQ:VERA) with a Overweight and raises the price target from $...

nvidia-is-up-186-from-a-year-ago-yet-these-7-stocks-have-more-than-doubled-their-returns-over-the-ai-chipmaker

Nvidia Is Up 186% From A Year Ago, Yet The...
05/29/2024 21:56:11

NVIDIA Corp. (NASDAQ:NVDA) has been the standout tech stock of the past year, leading the Nasdaq 100 index in the performance r...

Vera Therapeutics Receives FDA Breakthroug...
05/28/2024 12:05:29

Reported Saturday, Vera Therapeutics Prese...
05/28/2024 07:38:12

72-week data consistent with disease modification in IgAN, selected as a best-ranked abstract; Rapid and sustained improveme...

Raymond James Maintains Strong Buy on Vera...
05/10/2024 17:10:32

Raymond James analyst Steven Seedhouse maintains Vera Therapeutics (NASDAQ:VERA) with a Strong Buy and raises the price targ...

UPDATE: Vera Therapeutics Q1 EPS $(0.56) ...
05/09/2024 12:59:01

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.56) per share. This is a 30 percent increase over losses of $(...

vertexs-alpine-acquisition-unpacking-analyst-predictions-on-povetacicepts-potential-impact

Vertex's Alpine Acquisition: Unpacking Ana...
04/11/2024 18:47:33

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-media...

why-rallybio-shares-are-trading-higher-by-around-78-here-are-20-stocks-moving-premarket

Why Rallybio Shares Are Trading Higher By ...
04/11/2024 10:14:41

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collabo...